Previous 10 | Next 10 |
Although the healthcare sector has largely resisted this year's downward pressure, it is likely to succumb as pressure increases. Healthcare stocks have a well-deserved reputation for cyclical defense, but they are more likely to underperform in "secular" bear markets. Healthcare ...
Bridgewater Associates' 13F portfolio value increased ~45% from ~$17.20B to ~$24.81B this quarter. They more than doubled their stakes in emerging market ETFs this quarter. The top three individual stock positions are Procter & Gamble, Alibaba Group Holding, and Johnson & ...
Wedgewood Partners’ 13F portfolio value decreased from ~$753M to $709M this quarter. They increased Meta Platforms, Taiwan Semi, and PayPal while reducing Alphabet and Keysight Technologies. Their top five positions are at 38% of the overall portfolio. For further det...
Edwards Lifesciences is reporting high growth rates and the market could double until 2028. Considering what might come (potential recession and bear market), it is good to know that Edwards Lifesciences is more or less recession-proof. However, Edwards Lifesciences still seems to...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Edwards Lifesciences is well positioned to absorb cost headwinds in the medical technology segment. The company's propensity to drive free cash flow below the bottom line has ensured a robust schedule of growth in earnings and equity value. Recent pullbacks to its share price only...
EDWARDS LIFESCIENCES TO PRESENT AT THE BERNSTEIN 38TH ANNUAL STRATEGIC DECISIONS CONFERENCE PR Newswire IRVINE, Calif. , May 23, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced it is scheduled to present at the Bernst...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
EDWARDS ANNOUNCES KEY EVENTS FOR EUROPCR 2022 PR Newswire PARIS , May 16, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) announced key events for the company during EuroPCR 2022, the annual meeting of the European Association of Per...
Healthcare equipment and Medical Devices sector stood out during the covid-19 pandemic crisis and delivered strong returns over the medium and long term. Stocks from healthcare equipment and Medical Devices sector have performed poorly over the past one month, resulting in steep price...
News, Short Squeeze, Breakout and More Instantly...
Edwards Lifesciences Corporation Company Name:
EW Stock Symbol:
NYSE Market:
Edwards Lifesciences Corporation Website:
Edwards Lifesciences (NYSE: EW) today announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth. Edwards has entered into an agreement ...
Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2024 after the market closes on Wednesday, July 24, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877)...
Edwards Lifesciences (NYSE: EW) today announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an early-stage transcatheter mitral valve replacement (TMVR) company, following its initial investment in 2017. Since that time, Innovalve has demonstrated progress in its program wi...